International Clinical Trial: Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812246) titled 'Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: City of Hope Medical Center

Condition: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Intervention: Procedure: Biospecimen Collection Procedure: Bone Marrow Aspiration Procedure: Bone Marrow Biopsy Procedure: Computed Tomography Procedure: Lymph Node Biopsy Procedure: Magnetic R...